SNPHY Stock Price, Chart, Stats & News
Santen Pharmaceutical Co., Ltd. (SNPHY) is a dividend-paying stock with a current dividend yield of 1.59% as of Aug 14, 2026. It pays $0.1914 per share over the trailing twelve months and distributes bi-annually. Its dividend has grown at a -15.88% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — SNPHY pays out about 26% of earnings.
SNPHY chart
About
Santen Pharmaceutical Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan and international markets. The company maintains a significant pipeline and array of products focused on ophthalmic conditions. For glaucoma and ocular hypertension, their drug candidates encompass DE-111, currently undergoing Phase III clinical evaluation; DE-117, which is available in Japan; DE-126, now in Phase IIb trials; DE-128, being developed for European markets and also in Phase II/III trials within the United States; and DE-130A, another compound advancing through Phase III clinical trials.
Related lists
Similar securities
Based on sector and market capitalization
